To test the effect of the loss of TβRII expression in lung cancer, we have used lung adenocarcinoma cell line VMRC-LCD that is insensitive to growth inhibitory effects of TGF-β and that lacks TβRII expression. This evidence concerns the gene TGFBR2 and lung carcinoma.